Home › Funds › Tetragon Partners GP Ltd › ALKS
Tetragon Partners GP Ltd position in ALKS
ALKERMES PLC · Health Care
Tetragon Partners GP Ltd reported holding 189,979 shares of ALKS (ALKERMES PLC) in its Q2 2026 13F filing — a position valued at US$10.0M, representing 1.62% of its reported portfolio and ranking #14 among its reported holdings. Tetragon Partners GP Ltd has disclosed ALKS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Tetragon Partners GP Ltd's ALKS position evolved
Tetragon Partners GP Ltd first disclosed a stake in ALKS in Q2 2025 at 15,632 shares (US$447K). The position peaked in Q2 2026 at 189,979 shares, worth US$10.0M. Across 5 filings, Tetragon Partners GP Ltd increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 189,979 shares valued at US$10.0M — an increase of 30,188 shares quarter over quarter.. Notable position changes include a 473% increase in Q3 2025 (shares fell 7% over the following quarter), a 58% increase in Q4 2025 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 15.63K | $447.23K | New |
| Q3 2025 | 89.61K | $2.69M | Add |
| Q4 2025 | 141.17K | $3.95M | Add |
| Q1 2026 | 159.79K | $5.65M | Add |
| Q2 2026 | 189.98K | $9.95M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALKS and 13F data
ALKS (ALKERMES PLC) is a Health Care company. 43 other funds we track also report a position in ALKS — the largest reported positions include BAKER BROS. ADVISORS LP (US$524.6M), Renaissance Technologies (US$338.5M), Deep Track Capital, LP (US$209.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALKS
- BAKER BROS. ADVISORS LP 10.01M sh · $524.59M · Q2 2026
- Renaissance Technologies 6.46M sh · $338.52M · Q2 2026
- Deep Track Capital, LP 4.00M sh · $209.58M · Q2 2026
- Commodore Capital LP 3.00M sh · $157.19M · Q2 2026
- BVF INC/IL 2.15M sh · $112.90M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 1.94M sh · $101.54M · Q2 2026
- RTW INVESTMENTS, LP 1.67M sh · $87.62M · Q2 2026
- Soleus Capital Management, L.P. 1.03M sh · $53.93M · Q2 2026
More on Tetragon Partners GP Ltd
FAQ
How long has Tetragon Partners GP Ltd held ALKS?
Tetragon Partners GP Ltd has disclosed ALKS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Tetragon Partners GP Ltd's current position in ALKS?
As of Q2 2026, Tetragon Partners GP Ltd holds 189.98K shares of ALKS (ALKERMES PLC), valued at $9.95M, representing 1.62% of its reported portfolio and ranking #14.
Has Tetragon Partners GP Ltd been buying or selling ALKS?
In the latest 13F filing (Q2 2026), Tetragon Partners GP Ltd increased its position in ALKS. The position peaked in Q2 2026 at 189.98K shares.
Which other funds hold ALKS?
Other major institutional holders of ALKS include BAKER BROS. ADVISORS LP, Renaissance Technologies, Deep Track Capital, LP, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.